Revenue

RVL Pharmaceuticals claims double-digit growth for its eye drop Upneeq, but as a private firm, its disruptive direct-to-consumer model operates outside public view.

Paragon's new ActionKit Triggers enables AI agents to react to real-time events, aiming to consolidate the fragmented integration market.

A new virtual program offers hope for those with complex mental health needs, combining psychiatry, therapy, and biometrics into one coordinated team.

Citadel’s former CTO Umesh Subramanian joins Motive Partners, a move underscoring AI's new frontier and private equity's growing tech dominance.

The entertainment giant reported higher Q3 net income despite storms and weak consumer sentiment, leaning on AI-driven efficiencies and strategic acquisitions.

The architect of HUMIRA's launch and Horizon's $28B sale is now shaping the next wave of drug companies from within private equity. What does it mean?

A key supplier for data centers and pipelines, Drilling Mud Direct's acquisition by Broadwater Capital signals a major investment in America's infrastructure.

With a promising cancer pipeline, Crescent Biopharma heads to key May conferences to prove its strategy against fierce competition in the bispecific and ADC markets.

Telecom giant Liberty Global invests in AI security firm XBOW, signaling a strategic shift to proactive, machine-speed defense against evolving cyber threats.

Construction titan STO Building Group partners with Bespoke Metrics, mandating the COMPASS platform for 10,000+ subcontractors in a major industry shift.

Climate analytics firm Risilience appoints a new CEO to accelerate AI-powered growth as the market for environmental risk management soars.

Twin Disc reverses a prior-year loss with a $3.3M profit, driven by a 19% sales jump and record backlog, signaling a strong strategic turnaround.

Aptus Capital Advisors launches a new suite of deep buffered ETFs with a 0.25% fee, aiming to disrupt the market and offer a low-cost bond alternative.

A new partnership aims to unlock a $100B climate finance pipeline by putting sovereign environmental data on the Aptos blockchain, creating a trusted market.

A new advisory firm, AssetBuilt, launches with 200+ years of expertise, targeting the complex and booming EV and battery manufacturing asset market.

As the specialty chemicals market booms, firms are betting on AI. Uncountable's latest deals show how data is becoming the industry's most vital catalyst.

Backed by private equity, DTK unveils a bold strategy targeting AI, glass substrates, and a 2028 IPO, aiming for a high-tech transformation.

As EyePoint's losses widen to fund its lead drug, DURAVYU, the company is on the cusp of pivotal trial results that could redefine retinal disease treatment.

With strategic hires Valerie Layman and Katherine Tomera, BizTrip AI aims to upend corporate travel using its autonomous, agentic AI platform.

With the hire of a Project Maven expert, the investment firm signals a major push to embed advanced AI into its middle-market defense companies.